Structure for darunavir (A02.001 inhibitor)
 
| TERTIARY STRUCTURE DATA | ||||||||
|---|---|---|---|---|---|---|---|---|
| Comment | Resolution | PDB | PDBe | SCOP | CATH | PDBSum | Proteopedia | Reference |
| feline immunodeficiency virus retropepsin ( feline immunodeficiency virus) | ||||||||
| complex with darunavir | 1.70 Å | 3OGP | 3OGP | 3OGP | 3OGP | 3OGP | 3OGP | |
| HIV-1 retropepsin ( human immunodeficiency virus 1) | ||||||||
| complex with TMC114 inhibitor | 1.20 Å | 1T3R | 1T3R | 1T3R | 1T3R | 1T3R | 1T3R | Surleraux et al., 2005 |
| Asp30Asn mutant; complex with inhibitor TMC114 | 1.45 Å | 2F80 | 2F80 | 2F80 | 2F80 | 2F80 | 2F80 | |
| Leu90Met mutant; complex with inhibitor TMC114 | 1.25 Å | 2F81 | 2F81 | 2F81 | 2F81 | 2F81 | 2F81 | |
| Ile50Val mutant; complex with inhibitor TMC114 | 1.22 Å | 2F8G | 2F8G | 2F8G | 2F8G | 2F8G | 2F8G | |
| effect of flap mutations inhibition by saquinavir and darunavir | 1.40 Å | 3CYW | 3CYW | 3CYW | 3CYW | 3CYW | 3CYW | |
| Ile54Met mutant; complex with inhibitor darunavir | 1.30 Å | 3D1Z | 3D1Z | 3D1Z | 3D1Z | 3D1Z | 3D1Z | |
| multi-drug resistant variant (Leu10Phe/Gly48Val/Ile54Val/Val64Ile/Val82Ala); complex with darunavir (drv) | 1.97 Å | 3EKT | 3EKT | 3EKT | 3EKT | 3EKT | 3EKT | |
| Ile50Leu/Ala71val mutant; complex with inhibitor darunavir | 2.10 Å | 3EM6 | 3EM6 | 3EM6 | 3EM6 | 3EM6 | 3EM6 | |
| complex with darunavir | 1.95 Å | 3LZS | 3LZS | 3LZS | 3LZS | 3LZS | 3LZS | |
| nelfinavir resistant variant (Asn88Ser); complex with the protease inhibitor darunavir. | 1.76 Å | 3LZU | 3LZU | 3LZU | 3LZU | 3LZU | 3LZU | |
| nelfinavir-resistant variant (Asp30Asn/Asn88Asp); complex with darunavir. | 2.15 Å | 3LZV | 3LZV | 3LZV | 3LZV | 3LZV | 3LZV | |
| Ile50Val/Ala71Val variant; complex with the protease inhibitor darunavir | 1.95 Å | 3OXW | 3OXW | 3OXW | 3OXW | 3OXW | 3OXW | |
| Leu76Val variant; complex with the protease inhibitor darunavir. | 1.76 Å | 3OY4 | 3OY4 | 3OY4 | 3OY4 | 3OY4 | 3OY4 | |
| triple mutant Val32Ile/Ile47Val/Val82Ile; complex with antiviral drug darunavir in space group p212121 | 1.50 Å | 3S53 | 3S53 | 3S53 | 3S53 | 3S53 | 3S53 | |
| triple mutant Val32Ile/Ile47Val/Val82Ile; complex with antiviral drug darunavir in space group p21212 | 1.42 Å | 3S54 | 3S54 | 3S54 | 3S54 | 3S54 | 3S54 | |
| wild-type; complex with darunavir | 1.95 Å | 4LL3 | 4LL3 | 4LL3 | 4LL3 | 4LL3 | 4LL3 | |
| multidrug-resistant clinical isolate; complex with darunavir | 1.95 Å | 4NJT | 4NJT | 4NJT | 4NJT | 4NJT | 4NJT | |
| triple mutant (Val32Ile/Ile47Val/Val82Ile); complex with darunavir at ph 6.0 | 1.85 Å | 5E5J | 5E5J | 5E5J | 5E5J | 5E5J | 5E5J | |
| nl4-3 wt; complex with darunavir | 2.00 Å | 6DGX | 6DGX | 6DGX | 6DGX | 6DGX | 6DGX | |
| nl4-3 v82i mutant; complex with darunavir | 1.91 Å | 6DH3 | 6DH3 | 6DH3 | 6DH3 | 6DH3 | 6DH3 | |
| nl4-3 i50v mutant; complex with darunavir | 1.97 Å | 6DH6 | 6DH6 | 6DH6 | 6DH6 | 6DH6 | 6DH6 | |
| HIV-2 retropepsin ( human immunodeficiency virus 2) | ||||||||
| complex with clinical drug darunavir | 1.20 Å | 3EBZ | 3EBZ | 3EBZ | 3EBZ | 3EBZ | 3EBZ | |
